Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» long-acting insulin
long-acting insulin
Eli Lilly says experimental insulin could mean 313 fewer injections per year
Quartz
Thu, 09/5/24 - 11:50 am
Eli Lilly
long-acting insulin
diabetes
clinical trials
efsitora
Patients push back against Novo Nordisk move to scrap an insulin product
Reuters
Tue, 07/30/24 - 06:37 pm
Novo Nordisk
diabetes
insulin
Levemir
long-acting insulin
patients
Could This Drug News Give a Lift to Eli Lilly Stock?
Motley Fool
Mon, 01/2/23 - 06:27 pm
Eli Lilly
Rezvoglar
diabetes
Sanofi
Lantus
biosimilars
long-acting insulin
Sanofi touts head-to-head comparison of long-acting insulin products
Drug Delivery Business News
Mon, 12/4/17 - 11:48 am
Sanofi
insulin
diabetes
Toujeo
long-acting insulin
Novo Nordisk
Tresiba
Lilly, Boehringer’s Basaglar long-acting insulin now available in the U.S.
Mass Device
Thu, 12/15/16 - 06:41 pm
Eli Lilly
Boehringer Ingelheim
Basaglar
insulin
diabetes
long-acting insulin
Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product
Yahoo
Mon, 07/8/13 - 09:43 am
diabetes
Eli Lilly
Boehringer Ingelheim
Europe
LY2963016
long-acting insulin
biosimilars
Novo faces new hurdle in long-acting insulin race
Reuters
Wed, 07/18/12 - 11:52 am
Novo Nordisk
degludec
long-acting insulin